4-butyrolactone has been researched along with HPV Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adlercreutz, H; Dillner, J; Gislefoss, R; Hakama, M; Hallmans, G; Langseth, H; Lumme, S; Luostarinen, T; Saikku, P; Stattin, P; Stenman, UH; Tenkanen, L; Tuohimaa, P | 1 |
1 other study(ies) available for 4-butyrolactone and HPV Infection
Article | Year |
---|---|
Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.
Topics: 4-Butyrolactone; Adult; Blood Banks; Case-Control Studies; Chlamydia Infections; Chlamydia trachomatis; Cohort Studies; Finland; Human papillomavirus 18; Humans; Lignans; Longitudinal Studies; Male; Middle Aged; Norway; Papillomavirus Infections; Prostatic Neoplasms; Risk Factors; Sweden; Testosterone; Vitamin D | 2016 |